Variable | Status, no. (%) | p value* | |
---|---|---|---|
Still valid | Potential for update | ||
Guidelines topic | |||
Mental health, n = 26 | 23 (88.5) | 3 (11.5) | 0.32 |
Metabolic disease, n = 29 | 21 (72.4) | 8 (27.6) | |
Cancer and palliative care, n = 36 | 29 (80.6) | 7 (19.4) | |
Cardiovascular disease, n = 22 | 15 (68.2) | 7 (31.8) | |
SIGN strength of recommendations | n = 88 | n = 25 | |
A | 15 (17.0) | 3 (12.0) | 0.11 |
B | 13 (14.8) | 9 (36.0) | |
C | 6 (6.8) | 3 (12.0) | |
D | 12 (13.6) | 1 (4.0) | |
Good practice point | 42 (47.7) | 9 (36.0) | |
Clinical purpose | |||
Prevention | 32 (36.4) | 15 (60.0) | 0.14 |
Screening | 3 (3.4) | 0 (0.0) | |
Treatment | 49 (55.7) | 10 (40.0) | |
Others | 4 (4.5) | 0 (0.0) | |
Turnover | |||
Without references | 28 (31.8) | 0 (0.0) | 0.00 |
Low turnover | 37 (42.0) | 7 (28.0) | |
High turnover | 23 (26.1) | 18 (72.0) |
Note: SIGN = Scottish Intercollegiate Guidelines Network.
↵* Pearson χ2 test.